21 February 2011. Related: C.
compensatory mutation – this refer to an additional mutation, usually in the context of the fitness of a virus. For example, the mutations that stop a drug form working often stop the virus from reproducing as well. Additional mutations that …
21 February 2011. Related: R.
revertant mutation – this term is used in two ways. Firstly when referring to a genetic change that shows the virus is returning from a drug resistant mutation back to a wild-type genotype. This can sometimes take several stages. For …
21 February 2011. Related: R.
reverse transcriptase – an enzyme unique to HIV. It is used to convert single-strand RNA into double-strand DNA. This is needed before HIV’s genetic material can be integrated in the human DNA. HIV drugs that stop this process are called …
21 February 2011. Related: S.
superinfection – another term for reinfection.
21 February 2011. Related: R.
reinfection – catching HIV a second time. When an HIV-positive becomes infected with second strain or type of HIV. Sometimes called superinfection.
21 February 2011. Related: P.
phenotype test – a type of drug resistance that tests whether a drug is sensitive or resistance to a sample of HIV.
21 February 2011. Related: P.
partially active – the HIV treatment in question will work against this virus but this is reduced compared to wild-type HIV. This is the same as partial resistance, or intermediate resistance etc.
21 February 2011. Related: N.
nucleotide – the building blocks of the genetic code (DNA/RNA). Also called a base.
21 February 2011. Related: S.
secondary mutation – see minor mutation.
21 February 2011. Related: P.
primary mutation – see major mutation.
21 February 2011. Related: M.
minor mutation – a drug resistance mutation that have a big impact on whether a drug continues to work. This used to be called a secondary mutation.
21 February 2011. Related: M.
major mutation – a drug resistance mutation that have a big impact on whether a drug continues to work. This used to be called a primary mutation.
21 February 2011. Related: C.
clinical cut-off (CCO) – a test result that is associated with an impact on clinical care. With resistance tests a lower CCO is the level below which a drug is still sensitive or active. This is often set at a …
21 February 2011. Related: I.
Intermediate level resistance – when a drug still has some impact on HIV, but when this is reduced (compared to wild-type HIV) because there is some drug resistance.
21 February 2011. Related: H.
high level resistance – when an HIV drug no longer works against the virus.
21 February 2011. Related: G.
genotype test – a test that looks at how the genetic structure of a sample of HIV and whether the virus has changed with drug resistant mutations.
21 February 2011. Related: D.
drug resistant mutation – a mutation or change that occurs in the HIV genome that reduces a drugs ability to work.
21 February 2011. Related: D.
DNA – an abbreviation for the scientific word for genes and genetic material. It is the abbreviation for deoxyribonucleic acid. See RNA.
21 February 2011. Related: B.
baseline – baseline refers to the start of any period being studied. For someone who is HIV positive, their baseline CD4 and viral load counts are the first tests they ever had taken. For someone entering a study, the baseline …
21 February 2011. Related: A.
amino acids – amino acids are the building blocks of proteins. DNA codes for amino acids. Three nucleotides (segments of the genetic code) make one amino acid. Amino acids are critical to life, and have many functions in the way …